-
Balancing Vulnerability and Freedom: Perspectives on HIV Cure-Related Trials With Analytical Treatment Interruption Among People With HIV and Healthcare Practitioners in the United States
Mar 10, 2025, 14:00 PM -
Creation of a Novel Canadian Policy Model for Bladder Cancer
Mar 10, 2025, 14:00 PM -
How to Mitigate "Carer QALY Trap" when Including Caregiver QOL in Cost-Effectiveness Analysis: A Model Simulation Using Lecanemab in Japanese Patients with Alzheimer's Disease
Mar 10, 2025, 14:00 PM -
Market Access Challenges for Innovative Medications in Women's Health in Canada: Overview of the Past 20 Years
Mar 10, 2025, 14:00 PM -
Exploring the Broader Societal Value of Pembrolizumab in Triple-Negative Breast Cancer and Cervical Cancer in Brazil
Mar 10, 2025, 14:00 PM -
Real-World Disease Management Costs for U.S. Patients With Muscle Invasive Bladder Cancer (MIBC) Following Radical Cystectomy (RC) in Contemporary Practice
Mar 10, 2025, 14:00 PM -
Other Similar Measures? – How Different Really Are QALYs From Life Years, Health Years in Total, and Equal Value Life Years?
Mar 10, 2025, 14:00 PM -
Patient Value Assessment Using a Unified Measure Based on Data Envelopment Analysis: A Case Study
Mar 10, 2025, 14:00 PM -
Changes in Outpatient Visits in a Medicaid Population in the Face of Physician Shortages
Mar 10, 2025, 14:00 PM -
Economics of Prostate Cancer in Canada: A Systematic Review
Mar 10, 2025, 14:00 PM -
The Economic Benefit of Biosimilars in North America: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Estimating Costs Of Dispensing Services In Community Pharmacies In Taiwan Using A Time-Driven Activity-Based Costing Approach
Mar 10, 2025, 14:00 PM -
A Statistical Method for Quality Assessment of Demographic Variables in EHR Data
Mar 10, 2025, 14:00 PM -
Transcultural adaptation of the NutriQoL® questionnaire in American English
Mar 10, 2025, 14:00 PM -
To Bootstrap, or Not to Bootstrap Before Multiple Imputation: That Is the Question.
Mar 10, 2025, 14:00 PM -
Which Strategy is More Effective in Patients with Rheumatoid Arthritis (RA) and Metotrexate Failure: Adding Leflunomide or TNFi?
Mar 10, 2025, 14:00 PM -
Budget Impact Analysis of Volanesorsen as a Complement to the Diet in Adult Patients with Familial Chylomicronemia Syndrome (FCS) in Mexico
Mar 10, 2025, 14:00 PM -
Chronic Conditions Significantly Increase Risk of Severe RSV Outcomes in Medicaid Beneficiaries Aged 18-59 Years: A Claims Data Analysis
Mar 10, 2025, 14:00 PM -
Assessing Real-World Dosing Patterns for Vesicular Monoamine Transporter-2 Inhibitors (VMAT2i), Valbenazine and Deutetrabenazine, Among Patients with Tardive Dyskinesia (TD) in a Nationwide US Claims Database
Mar 10, 2025, 14:00 PM -
Development of New Patient Reported Outcome (PRO) Conceptual Models for Treatment Adherence and Satisfaction in People with HIV
Mar 10, 2025, 14:00 PM
